FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam
(Reuters) – Gilead Sciences Inc (GILD.O) said on Friday it provided its experimental Ebola therapy for use in a small number of patients with the Wuhan coronavirus and is working with China’s health authorities to set up a trial to test the drug against the virus.
The company said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus.
Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Maju Samuel
Our Standards:The Thomson Reuters Trust Principles.
This article was originally published by Reuters.com. Read the original article here.